氣道清除設備市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

2024 年全球氣道清理設備市場規模達到 6.486 億美元，預計 2025-2034 年期間的複合年成長率為 4.8%。這種成長是由多種因素推動的，包括持續的技術進步、慢性呼吸系統疾病發病率的上升、人口老化以及醫院內感染發病率的上升等。

市場按設備類型細分，主要類別包括肺內衝擊通氣 (IPV)、高頻胸壁振盪 (HFCWO)、機械咳嗽輔助裝置、撲動黏液清除裝置、呼氣正壓 (PEP) 等。其中，HFCWO 細分市場在 2024 年引領市場，創造了可觀的收入。 HFCWO 設備因其非侵入性而越來越受歡迎，它為患者提供了一種舒適的氣道清除方法。這些設備使用方便，無需患者主動參與即可提供一致的治療，特別適合老年和兒科患者。

依年齡層來看，市場分為成人市場和兒童市場。成人市場在 2024 年佔據最大佔有率，預計在整個預測期內將繼續佔據主導地位，到 2034 年市場價值將達到 6.54 億美元。家庭治療的日益普及進一步推動了這種需求。成年人越來越喜歡攜帶式、方便用戶使用的氣道清除設備，這種設備使他們能夠舒適地在家中管理慢性呼吸系統疾病，從而減少頻繁去醫院的需要。

2024 年北美氣道清除設備市場規模為 2.546 億美元，預計 2025-2034 年期間的複合年成長率為 3%。北美的慢性呼吸系統疾病發生率很高，這大大增加了對先進的氣道清除技術的需求。該地區完善的醫療保健基礎設施和廣泛使用的創新醫療設備使其成為在臨床和家庭護理環境中採用氣道清除設備的理想環境。預計這一趨勢將推動市場持續成長，改善整個地區的患者管理和治療效果。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 呼吸系統疾病發生率上升
    • 提高患者意識和產品發布
    • 非侵入性治療方案的採用率不斷提高
    • 政府加強控制呼吸系統疾病
  • 產業陷阱與挑戰
    • 設備成本高且監管要求嚴格
• 成長潛力分析
• 2023 年定價分析
• 監管格局
  • 美國
  • 歐洲
• 報銷場景
• 技術格局
• 價值鏈分析
• 應用潛力
• 措施/政策前景
• 差距分析
• 未來市場趨勢
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 競爭定位矩陣
• 供應商矩陣分析
• 策略儀表板

第 5 章：市場估計與預測：按設備類型，2018 – 2032 年

• 主要趨勢
• 高頻胸壁振動（HFCWO）
• 撲動黏液清除裝置
• 肺內衝擊通氣 (IPV)
• 機械性咳嗽輔助裝置
• 呼氣正壓（PEP）
• 其他設備類型

第6章：市場估計與預測：按應用，2018 – 2032 年

• 主要趨勢
• 慢性阻塞性肺病（COPD）
• 支氣管擴張
• 囊腫纖維化
• 神經肌肉
• 其他應用

第7章：市場估計與預測：依年齡層，2018 – 2032 年

• 主要趨勢
• 成人
• 兒科

第 8 章：市場估計與預測：依最終用途，2018 – 2032 年

• 主要趨勢
• 醫院
• 家庭護理設置
• 門診手術中心
• 其他最終用途

第 9 章：市場估計與預測：按地區，2018 – 2032 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• ABM Respiratory Care
• Baxter International/Hill-Rom Holdings
• Dima Italia
• Dymedso
• Electromed
• ICU Medical
• Koninklijke Philips NV
• Mercury Medical
• Monaghan Medical
• Pari Medical
• Pneumo Care Health
• Sentec
• Tactile Medical
• Thayer Medical
• VORTRAN Medical
• VYAIRE MEDICAL

The Global Airway Clearance Devices Market reached USD 648.6 million in 2024 and is projected to grow at a CAGR of 4.8% during 2025-2034. This growth is driven by several factors, including ongoing technological advancements, the rising prevalence of chronic respiratory diseases, an aging population, and the increasing incidence of hospital-acquired infections, among others.

The market is segmented by device type, with key categories including intrapulmonary percussive ventilation (IPV), high-frequency chest wall oscillation (HFCWO), mechanical cough assist devices, flutter mucus clearance devices, positive expiratory pressure (PEP), and others. Among these, the HFCWO segment led the market in 2024, generating significant revenue. HFCWO devices are gaining popularity due to their non-invasive nature, offering patients a comfortable airway clearance method. These devices are easy to use and deliver consistent therapy without requiring active participation from the patient, making them particularly suitable for elderly and pediatric patients.

In terms of age group, the market is divided into adult and pediatric segments. The adult segment held the largest share in 2024 and is expected to continue its dominance throughout the forecast period, reaching a market value of USD 654 million through 2034. Adults, particularly those recovering from thoracic or abdominal surgeries or respiratory infections, often need airway clearance therapy to avoid complications. This demand is further fueled by the growing trend of home-based treatments. Adults increasingly prefer portable, user-friendly airway clearance devices that enable them to manage chronic respiratory conditions from the comfort of their own homes, reducing the need for frequent hospital visits.

North American airway clearance devices market accounted for USD 254.6 million in 2024 and is expected to grow at a CAGR of 3% during 2025-2034. North America has a high incidence of chronic respiratory conditions, which significantly contributes to the demand for advanced airway clearance technologies. The region's well-established healthcare infrastructure and widespread access to innovative medical devices make it an ideal environment for the adoption of airway clearance devices in both clinical and home care settings. This trend is expected to drive continued market growth, improving patient management and outcomes across the region.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rise in incidence of respiratory conditions
    • 3.2.1.2 Growing patient awareness and product launches
    • 3.2.1.3 Increasing adoption of non-invasive treatment options
    • 3.2.1.4 Surge in government initiatives towards controlling respiratory disorders
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High device cost and stringent regulatory requirements
• 3.3 Growth potential analysis
• 3.4 Pricing analysis, 2023
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Reimbursement scenario
• 3.7 Technological landscape
• 3.8 Value chain analysis
• 3.9 Application potential
• 3.10 Initiatives/policy landscape
• 3.11 GAP analysis
• 3.12 Future market trends
• 3.13 Porter's analysis
• 3.14 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Vendor matrix analysis
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 – 2032 ($ Mn, Units)

• 5.1 Key trends
• 5.2 High frequency chest wall oscillation (HFCWO)
• 5.3 Flutter mucus clearance device
• 5.4 Intrapulmonary percussive ventilation (IPV)
• 5.5 Mechanical cough assist devices
• 5.6 Positive expiratory pressure (PEP)
• 5.7 Other device types

Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Chronic obstructive pulmonary disease (COPD)
• 6.3 Bronchiectasis
• 6.4 Cystic fibrosis
• 6.5 Neuromuscular
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Age Group, 2018 – 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By End Use, 2018 – 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospital
• 8.3 Homecare settings
• 8.4 Ambulatory surgical centers
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 ABM Respiratory Care
• 10.2 Baxter International/Hill-Rom Holdings
• 10.3 Dima Italia
• 10.4 Dymedso
• 10.5 Electromed
• 10.6 ICU Medical
• 10.7 Koninklijke Philips N.V.
• 10.8 Mercury Medical
• 10.9 Monaghan Medical
• 10.10 Pari Medical
• 10.11 Pneumo Care Health
• 10.12 Sentec
• 10.13 Tactile Medical
• 10.14 Thayer Medical
• 10.15 VORTRAN Medical
• 10.16 VYAIRE MEDICAL